• 1. Co(ii), Ni(ii) and Cu(ii) complexes with phenylthiazole and thiosemicarbazone-derived ligands: synthesis, structure and cytotoxic effects
  Marta Sobiesiak,Tadeusz Muzio?,Marek Rozalski,Urszula Krajewska,Elzbieta Budzisz New J. Chem. 2014 38 5349
• 2. New anellated 4H-1,4,2-diazaphospholes
  Wolfgang Betzl,Christina Hettstedt,Konstantin Karaghiosoff New J. Chem. 2013 37 481
• 3. Synthesis of Some New Biologically Active 5-Phenoxy-4-phenyl-1,3-thiazol-2-amines
  M. M. V. Ramana,Deepnandan S. Dubhashi,Joseph J. D'Souza J. Chem. Res. (S) 1998 496
• 4. 313. Synthetic applications of activated metal catalysts. Part III. Desulphurisation of thiazoles with Raney nickel
  G. M. Badger,N. Kowanko J. Chem. Soc. 1957 1652
• 5. Direct preparation of thiazoles, imidazoles, imidazopyridines and thiazolidines from alkenes
  Timothy J. Donohoe,Mikhail A Kabeshov,Akshat H. Rathi,Ian E. D. Smith Org. Biomol. Chem. 2012 10 1093

4-Phenyl-1,3-Thiazole: An Overview of a Promising Heterocyclic Compound (CAS No. 1826-12-6)

4-Phenyl-1,3-thiazole (CAS No. 1826-12-6) is a heterocyclic compound that has garnered significant attention in the fields of medicinal chemistry and pharmaceutical research. This compound, characterized by its unique thiazole ring and phenyl substituent, exhibits a range of biological activities that make it a valuable candidate for various applications, including drug discovery and development.

The thiazole ring, a five-membered heterocycle containing one sulfur and one nitrogen atom, is a common structural motif found in numerous bioactive molecules. The presence of the phenyl group in 4-phenyl-1,3-thiazole further enhances its pharmacological properties by influencing its electronic and steric characteristics. This combination of structural features has led to extensive research into the potential therapeutic applications of this compound.

Recent studies have highlighted the diverse biological activities of 4-phenyl-1,3-thiazole. One notable area of interest is its anti-inflammatory properties. Research published in the Journal of Medicinal Chemistry has demonstrated that 4-phenyl-1,3-thiazole derivatives can effectively inhibit the production of pro-inflammatory cytokines, such as interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α), making them potential candidates for the treatment of inflammatory diseases.

In addition to its anti-inflammatory effects, 4-phenyl-1,3-thiazole has shown promise as an antimicrobial agent. Studies have reported that certain derivatives of this compound exhibit potent activity against a range of bacterial and fungal pathogens. For instance, a study published in the European Journal of Medicinal Chemistry found that specific 4-phenyl-1,3-thiazole derivatives displayed significant antibacterial activity against methicillin-resistant Staphylococcus aureus (MRSA), a notorious pathogen responsible for many hospital-acquired infections.

The antitumor properties of 4-phenyl-1,3-thiazole have also been extensively investigated. Research conducted by scientists at the National Cancer Institute has shown that certain derivatives of this compound can induce apoptosis in cancer cells and inhibit tumor growth. These findings suggest that 4-phenyl-1,3-thiazole-based compounds may have potential as novel anticancer agents.

Beyond its direct biological activities, 4-phenyl-1,3-thiazole serves as an important building block in the synthesis of more complex molecules. Its versatility as a synthetic intermediate has been leveraged in the development of various pharmaceuticals and agrochemicals. For example, it has been used in the synthesis of selective serotonin reuptake inhibitors (SSRIs), which are widely used to treat depression and anxiety disorders.

The synthetic accessibility of 4-phenyl-1,3-thiazole is another factor contributing to its popularity in research and development. Various methods have been developed for its synthesis, including cyclization reactions involving thiols and nitriles or amides. These synthetic routes are generally efficient and can be readily scaled up for industrial production.

In conclusion, 4-phenyl-1,3-thiazole (CAS No. 1826-12-6) is a versatile heterocyclic compound with a wide range of biological activities and synthetic applications. Its anti-inflammatory, antimicrobial, and antitumor properties make it a valuable candidate for further exploration in medicinal chemistry and drug discovery. As research continues to uncover new insights into its mechanisms of action and potential therapeutic uses, 4-phenyl-1,3-thiazole-based compounds are likely to play an increasingly important role in the development of novel pharmaceuticals.

• 383143-37-1(4-(2,4-Dimethylphenyl)-1,3-thiazole)
• 1826-16-0(2-Methyl-4-phenylthiazole)
• 134812-28-5(3-(1,3-thiazol-4-yl)aniline)
• 1826-22-8(4-(4-Chlorophenyl)-1,3-thiazole)
• 383145-33-3(4-(3-Methylphenyl)-1,3-thiazole)
• 96461-06-2(4-(2-Naphthyl)-1,3-thiazole)
• 1826-20-6(4-(4-Bromophenyl)thiazole)
• 383143-39-3(4-(2,5-Dimethylphenyl)-1,3-thiazole)
• 1826-19-3(4-(4-Methylphenyl)-1,3-thiazole)
• 60759-10-6(4-(4-Aminophenyl)thiazole)